Specificity protein 1, Specificity protein 3, Specificity protein 4 (Sp1, Sp3, Sp4)

Sp1, Sp3, and Sp4 are tightly related transcription factors that bind GC-rich sequences on gene promoters, serving as master regulators of gene expression for key processes such as cell proliferation, differentiation, apoptosis, and responses to cellular stress. They are characterized by the presence of Cys2-His2 zinc finger DNA-binding motifs and are subject to complex regulation by posttranslational modifications. Overexpression—particularly of Sp1—is frequently observed in cancer, making them attractive targets for chemotherapy and cancer prevention. Beyond oncology, their functions extend to cardiovascular disease and metabolic disorders, where they influence disease course through control of genes involved in inflammation, cell death, and tissue remodeling. Drugs that modulate Sp protein activity are under investigation as targeted therapies, but therapeutic modulation requires careful consideration due to their widespread physiological importance.

Other names

Sp1 transcription factorSp3 transcription factorSp4 transcription factorTranscription factor Sp1/Sp3/Sp4SP1/SP3/SP4GC-box binding proteins

Inhibition of Sp1 binding to GC-rich promoter regions, leading to downregulation of pro-oncogenic gene expression. Disruption of transcriptional initiation and repression of genes driving cancer cell proliferation, survival, migration, and invasion. Modulation of posttranslational modifications affecting Sp activity (phosphorylation, acetylation, glycosylation, proteolysis).